In a genetically modified mouse model of T2DM, Drp1 was selectively deleted in podocytes, which can ameliorate mitochondrial dysfunction and protect against the progression of DKD (Ayanga et al., 2016). The gene discussed is DNM1L; the disease is diabetic kidney disease.